Increasing Utilization of biologic agents to Foster the Ortho Biological Products Market

Published: Apr 2022

The global ortho biological products market is anticipated to grow at a considerable CAGR of 4.3% during the forecast period (2022-2028). The growing utilization of biologic agents such as platelet-rich plasma and stem cell therapy along with the rise in cell-based matrices is expected to offer lucrative growth opportunities in the global ortho biological products market. Furthermore, increasing adoption of bone marrow aspirate concentrate, adipose-derived stromal cells, and autologous conditioned serum is also expected to boost the market.

Browse the full report of " Global Ortho Biological Products Market Size, Share & Trends Analysis Report By Type (Viscosupplementation, Demineralized Bone Matrices (DBM), Bone Morphogenic Protein (BMP), Allografts, and Others), By Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Trauma, Reconstructive Surgeries, and Others), Forecast 2022-2028" at https://www.omrglobal.com/industry-reports/ortho-biological-products-market

However, lack of reimbursement, stringent regulations, complex synthesization processes, and strict regulations for manufacturing may hamper the growth of the ortho biological products market. Furthermore, the global ortho biologics market is witnessing fluctuations in the cost of ortho biologics along with expensive production costs. For instance, as per the information provided in October 2019, by the University of Alabama that highlighted the fact that, significant cost variability ranging from a few hundred dollars to as much as US$ 12,000 in ortho biologics therapies. Further, the key players operating in the global ortho biological products market had been adopting strategies such as new launches and agreements to gain major market share. On July 28, 2021, Orthofix Medical Inc., had introduced fiberFUSE strip in the US, which is considered as an advanced demineralized fiber bone graft solution containing cancellous bone.

Market Coverage

  • The market number available for – 2021-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered

o By Type

o By Application

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- including Baxter International Inc., Johnson & Johnson Services, Inc., Medtronic Plc, Royal Biologics, Surgalign Holdings Inc., and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Ortho Biological Products Market Report Segment

By Type

  • Viscosupplementation Products
  • Demineralized Bone Matrices (DBM)
  • Bone Morphogenic Protein (BMP)
  • Allografts
  • Others (Machined Bones, Plasma-rich Protein)

By Application

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Trauma
  • Reconstructive Surgeries
  • Others (Soft-tissue Injuries)

Global Ortho Biological Products Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa